Application Note: Human Endometrial Organoids as a New Approach Methodology (NAM) for Preclinical Cytotoxicity Testing in Women’s Reproductive Health

We present patient-derived endometrial organoids as a sensitive and scalable model for reproductive toxicity screening, aligning with FDA and NIH priorities for human-based NAMs.